|
Real-time Estimate
Cboe BZX
13:46:36 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.3910 USD | +2.65% |
|
+0.10% | -70.71% |
| 08-07 | Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-08 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- SNGX Stock
- Consensus Soligenix, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
